Evidence map›Paper›PMID 41563381›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Patient-Focused Drug Development in Kidney Disease: Including Fit-for-Purpose Outcomes in Trials.

John Devin Peipert, Louise Oni, Olalekan Lee Aiyegbusi, Nicola Anderson, Melanie Calvert, Laurel Damashek, Libby Thomas, Howard Trachtman, Eloise Salmon

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John Devin PeipertDepartment of Applied Health Sciences, Centre for Patient-Reported Outcomes Research (CPROR), College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-5762-7881
Louise OniDepartment of Renal Medicine, UCL Centre for Kidney and Bladder Health, University College London, London, United Kingdom.ORCID 0000-0002-1532-2390
Olalekan Lee AiyegbusiDepartment of Applied Health Sciences, Centre for Patient-Reported Outcomes Research (CPROR), College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-9122-8251
Nicola AndersonDepartment of Applied Health Sciences, Centre for Patient-Reported Outcomes Research (CPROR), College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-0614-3198
Melanie CalvertDepartment of Applied Health Sciences, Centre for Patient-Reported Outcomes Research (CPROR), College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-1856-837
Laurel DamashekInternational Society of Glomerular Disease, Florence, Massachusetts.ORCID 0009-0004-7776-7995
Libby ThomasDepartment of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Howard TrachtmanDivision of Nephrology, Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0006-7778-292
Eloise SalmonDivision of Nephrology, Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0974-3719

Funding

Center for Drug Evaluation and Research UH3FD007308
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialkidney diseasepatient self-assessmentquality of life

Identifiers

PMID41563381
PMCPMC12935343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.